Skip to main content
. 2010 Nov;51(11):3217–3229. doi: 10.1194/jlr.M007518

TABLE 2.

LC-FA composition from the whole retinas collected from young, middle, and old age and age-matched AMD human donors

Mole % of Total FAsd
Peak no.a RT (min)b FAsc Common Name Young Age Group Middle Age Group Old Age Group Age-Matched AMD Group
1 23.51 14:0 Tetradecanoic acid 0.50 ± 0.06 0.60 ± 0.06 0.61 ± 0.05 0.81 ± 0.09
2 26.42 15:0 Pentadecanoic acid 0.15 ± 0.05 0.12 ± 0.02 0.11 ± 0.01 0.21 ± 0.04
3 29.06 16:1n-9 7-Hexadecenoic acid 0.91 ± 0.14 0.66 ± 0.09 0.62 ± 0.04 0.76 ± 0.09
4 29.24 16:1n-7 9-Hexadecenoic acid 0.48 ± 0.03 0.49 ± 0.05 0.36 ± 0.03 0.50 ± 0.07
5 30.39 16:0 PA 15.98 ± 1.18 16.37 ± 1.37 16.62 ± 0.79 19.64 ± 1.79
6 34.45 17:0 Heptadecanoic acid 0.12 ± 0.04 0.08 ± 0.02 0.07 ± 0.02 0.14 ± 0.02
7 36.61 18:3n-3 α-Linolenic acid 0.39 ± 0.07 0.24 ± 0.06 0.24 ± 0.05 0.30 ± 0.04
8 37.38 18:2n-6 LA 1.63 ± 0.13 2.12 ± 0.15 1.93 ± 0.20 2.35 ± 0.24
9 37.85 18:1n-9 OA 14.88 ± 0.46 16.04 ± 1.56 14.53 ± 1.11 17.14 ± 1.38
10 38.02 18:1n-7 11-Octadecenoic acid 2.79 ± 0.17 2.83 ± 0.12 2.57 ± 0.25 3.08 ± 0.23
11 39.18 18:0 Octadecanoic acid/SA 14.80 ± 1.15 13.50 ± 0.46 13.91 ± 0.53 15.45 ± 0.98
12 44.47 20:4n-6 AA 13.43 ± 0.34 14.26 ± 0.64 14.04 ± 0.47 13.04 ± 0.36
13 44.64 20:5n-3 5,8,11,14,17-EPA 0.27 ± 0.03 0.28 ± 0.03 0.24 ± 0.04 0.35 ± 0.05
14 45.18 20:3n-6 8,11,14- Eicosatrienoic acid 2.38 ± 0.28 2.63 ± 0.14 2.29 ± 0.27 2.57 ± 0.26
15 45.44 20:2n-7 8,11-Eicosadienoic acid 0.09 ± 0.03 0.13 ± 0.05 0.10 ± 0.03 0.18 ± 0.02
16 45.99 20:2n-9 11,14-Eicosadienoic acid 0.09 ± 0.02 0.09 ± 0.02 0.14 ± 0.02 0.16 ± 0.04
17 46.23 20:1n-9 9-Eicosenoic acid 0.24 ± 0.04 0.29 ± 0.04 0.37 ± 0.04 0.55 ± 0.14
18 46.51 20:1n-7 11-Eicosenoic acid 0.17 ± 0.06 0.10 ± 0.05 0.03 ± 0.00 0.04 ± 0.01
19 47.42 20:0 Eicosanoic acid 0.65 ± 0.03 0.66 ± 0.01 0.82 ± 0.09 1.11 ± 0.15
20 51.90 22:5n-6 4,7,10,13,16-Docosapentaenoic acid 1.42 ± 0.33 1.03 ± 0.28 1.41 ± 0.31 1.02 ± 0.17
21 52.30 22:6n-3 4,7,10,13,16,19-DHA 23.74 ± 1.48 21.75 ± 2.78 23.01 ± 1.65 16.49 ± 0.62e*
22 52.50 22:4n-6 7,10,13,16-Docosatetraenoic acid (adrenic acid) 2.21 ± 0.40 2.53 ± 0.38 2.82 ± 0.37 1.61 ± 0.29e*
23 52.76 22:5n-3 7,10,13,16,19-Docosapentaenoic acid 1.52 ± 0.29 1.94 ± 0.36 1.77 ± 0.34 1.24 ± 0.25
24 55.39 22:0 Behenic acid 0.31 ± 0.02 0.40 0.03 0.41 ± 0.04 0.41 ± 0.03
25 61.83 24:1n-9 15-Tetracosenoic acid 0.66 ± 0.15 0.56 ± 0.10 0.71 ± 0.13 0.60 ± 0.15
26 62.75 24:0 Tetracosanoic acid 0.20 ± 0.03 0.31 ± 0.03 0.28 ± 0.04 0.25 ± 0.04
Ratio of AA/DHA 0.58 ± 0.05 0.76 ± 0.17 0.63 ± 0.06 0.79 ± 0.02e*
Ratio of n-6/n-3 LC-PUFAs 0.83 ± 0.05 1.05 ± 0.20 0.91 ± 0.06 1.13 ± 0.04e*
a

Peak no. was shown in chromatograms of Fig. 1.

b

Retention time.

c

Number of carbon atoms: number of double bonds, the position of first double bound.

d

Mean ± SEM; young age group: n = 5, middle age group: n = 6, old age group: n = 5, age-matched AMD group: n = 8.

e

* Significant differences (P < 0.05) between old age and age-matched AMD group.